| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 309.38M | 301.13M | 288.65M | 315.45M | 263.22M | 293.60M |
| Gross Profit | 56.12M | 52.96M | 53.07M | 53.79M | 52.81M | 56.97M |
| EBITDA | -20.33M | -32.33M | -6.05M | -34.22M | 4.98M | 10.39M |
| Net Income | -39.79M | -51.43M | -20.62M | -47.00M | -12.76M | -12.24M |
Balance Sheet | ||||||
| Total Assets | 308.78M | 267.27M | 323.97M | 354.08M | 458.33M | 466.55M |
| Cash, Cash Equivalents and Short-Term Investments | 86.45M | 109.44M | 140.25M | 116.48M | 180.55M | 199.35M |
| Total Debt | 174.26M | 184.61M | 179.94M | 188.91M | 245.36M | 236.14M |
| Total Liabilities | 229.83M | 217.57M | 233.15M | 236.75M | 286.61M | 285.73M |
| Stockholders Equity | 78.95M | 50.90M | 90.32M | 117.34M | 171.71M | 180.83M |
Cash Flow | ||||||
| Free Cash Flow | -33.52M | -26.53M | 40.56M | 22.33M | 1.17M | -16.49M |
| Operating Cash Flow | -28.17M | -14.98M | 42.29M | 24.36M | 4.91M | -11.90M |
| Investing Cash Flow | -1.76M | -12.29M | 331.77K | 28.54M | -6.75M | -63.97M |
| Financing Cash Flow | 1.55M | -3.68M | -20.36M | -68.35M | -3.43M | -16.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$97.44M | 0.44 | 11.01% | 10.17% | 52.69% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$182.60M | 0.50 | 10.06% | ― | -17.67% | 1010.71% | |
47 Neutral | HK$114.36M | 13.37 | -46.48% | ― | -0.64% | 13.72% | |
47 Neutral | HK$74.67M | -1.08 | -12.80% | ― | 11.27% | -1272.22% | |
44 Neutral | HK$37.42M | 0.01 | ― | ― | ― | ― |
Wan Kei Group Holdings has completed a share placing under its general mandate, issuing 50.68 million new shares at HK$0.25 each to at least six placees, representing 20% of its issued share capital before the deal and 16.66% after enlargement. The transaction is intended to strengthen liquidity without incurring interest, provide supplementary working capital to address cash burn and timing mismatches in customer payments, reduce reliance on related-party funding, and broaden the shareholder base to improve trading liquidity of the stock.
As of 31 December 2025, the group held HK$103.3 million in cash and equivalents but estimates it needs around HK$113 million to fund operations across its various business lines, including provisions for long service payments and loan and interest repayments. Management highlighted that the fresh capital will enhance financial flexibility amid possible lengthening payment cycles and macroeconomic pressures, while positioning the company to capture future business development and investment opportunities of interest to professional and institutional investors.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.48 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.
Wan Kei Group Holdings Limited has agreed to acquire 70% of House Clover Ventures Limited, a British Virgin Islands company engaged in the food and beverage business, for HK$2.31 million. The target operates two premium coffee shops in prime Shanghai locations under an exclusive distribution and trademark licence with a renowned Japanese coffee brand, and runs an online platform selling branded coffee beans and related products. Following completion, House Clover Ventures will become a non-wholly-owned subsidiary and its financial results will be consolidated into Wan Kei’s accounts. The board views the deal as a strategic move to enter Shanghai’s fast-growing premium coffee retail market, diversify the group’s operations and revenue streams across physical and e-commerce channels, and enhance overall business performance and profitability for shareholders.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.28 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.
Wan Kei Group Holdings Limited has entered into a placing agreement to issue up to 50,688,000 new shares under its existing general mandate at HK$0.25 per share, representing a discount to recent market prices. The new shares will amount to 20% of the company’s current issued share capital, or about 16.67% on an enlarged basis, raising gross proceeds of approximately HK$12.7 million (about HK$12.5 million net) if fully placed. Management plans to use all of the net proceeds for general working capital, primarily to fund directors’ fees, staff salaries, rental expenses, and legal and professional fees, signalling a focus on shoring up day-to-day operations rather than financing new projects. The placing, which will be conducted on a best-effort basis by an independent placing agent to at least six independent investors, remains subject to conditions under the agreement, meaning completion is not guaranteed and existing shareholders face potential dilution if it proceeds.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.34 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.
Wan Kei Group Holdings Limited has issued a supplemental announcement regarding its previously disclosed acquisition of 51% of the issued share capital of a target company, detailing the independent valuation that underpins the transaction consideration. The valuation, conducted by Ascent Partners Valuation Service Limited using a market approach and the Guideline Public Company Method, appraised the 51% stake at HK$16.9 million as of 30 September 2025, based on a median price-to-earnings multiple of 15.05, trailing 12‑month earnings of HK$2.09 million, and adjustments for lack of marketability and a premium for control. The decision to adopt the market approach, rather than cost or income approaches, reflects the availability of comparable listed peers and the desire to capture current market expectations for the industry, providing shareholders and stakeholders with greater transparency on how the acquisition price was determined and supporting the board’s assertion that the terms are fair and reasonable on an arm’s‑length basis.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.35 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.
Wan Kei Group Holdings Limited has announced the resignation of non-executive director Mr. Lui Kwok Wai, effective 18 December 2025, as he steps down to devote more time to personal commitments, with both the board and Mr. Lui indicating there is no disagreement or matter requiring shareholder attention. Concurrently, the company has adjusted the composition of its investment committee, with Mr. Lui ceasing to be a member and independent non-executive director Mr. Jiang Senlin appointed in his place, a move that maintains compliance with the committee’s terms of reference and signals continuity in the governance of the group’s investment oversight.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.35 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.
Wan Kei Group Holdings Limited has announced the composition of its board of directors and outlined the structure of its key board committees. The company has appointed Bai Huawei and Wang Yu as executive directors, Xu Lin as non-executive chairman, and Jiang Senlin, Zhang Yi and Dan Xi as independent non-executive directors, and detailed their respective roles on the audit, nomination, remuneration and investment committees, indicating a clarified governance framework and delineation of oversight responsibilities.
The most recent analyst rating on (HK:1718) stock is a Hold with a HK$0.35 price target. To see the full list of analyst forecasts on Wan Kei Group Holdings Limited stock, see the HK:1718 Stock Forecast page.